General Announcement::Company Statement

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Oct-2024 19:17:04
Status
New
Announcement Sub Title
Company Statement
Announcement Reference
SG241030OTHROZOQ
Submitted By (Co./ Ind. Name)
Akhilesh Nand - Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
30/10/2024 16:30:00
Description (Please provide a detailed description of the event in the box below)
Please find enclosed the company statement titled Biocon Biologics Drug Substance Facility in Bengaluru Classified as Voluntary Action Indicated (VAI).

Attachments

BBL_SGX_30102024 - Company Statement.pdf
Total size =539K